Reform progress and achievements of China's incentive policies for pediatric medicine over the last decade.

For instance, in the case of cardiovascular drugs, there has been a clear trend of pediatric drugs shifting from liquid formulations to smaller solid (multiple granule) or orally disintegrating formulations since the regulation was enacted ( Thabet et al., 2018 ).

also in 19,460 other papers